£400K
Cross Border Angels & Experts has backed the animal health startup through its Seed-2-Growth programme.
T
Tharos
Tharos creates enzyme rich malt extract supplements to improve animal gut health and performance.
United Kingdom—Founded 2015
£400KTotal raised
Tharos develops enzyme rich malt extract supplements to improve digestive health and performance in horses and other animals.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from Tharos's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
Harry Paul
CEO
Harry brings investment experience across HealthTech and enabling technologies as a partner at Access India Ventures. He also holds leadership and advisory roles at Viresco Group, MI:RNA Diagnostics, and LatAm HQ Health.
LinkedIn